- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Consumer
DoorDash orders up $8.1bn Wolt acquisition
Prosus Ventures is set to exit the food and consumer goods delivery service in an all-stock deal which will boost DoorDash's international aspirations.
Nov 10, 2021Daily Deal Round Up: November 9, 2021
DivcoWest, JLL and Allegion combined in a $60m round for workplace data platform developer VergeSense while Sanofi committed up to $60m to ocular therapeutics developer Gyroscope.
Nov 9, 2021Xiaohongshu sells corporates on $500m round
Alibaba and Tencent contributed to a late-stage round reportedly valuing the social commerce platform developer at up to $20bn.
Nov 9, 2021Analysis: ABL raises $370m in series B
Satellite launch vehicle developer ABL Space Systems raised a multimillion dollar series B round, which took its total funding to $420m with a $200m extension to its latest round.
Nov 8, 2021Fuelling energy technologies that can save the planet
While COP26 is about to start and the representatives of almost 200 countries prepare to gather in Glasgow for what has been described as “the world’s best last chance to get runaway climate change under control”, the energy industry is in the middle of a profound metamorphosis that could radically reshape global power production and transform our relationship with the planet’s natural resources.
Nov 5, 2021Solid returns are key to realising zero emissions goal
Global Energy Council Q4 2021 editorial by James Mawson, editor in chief, Global Corporate Venturing
Nov 5, 2021Daily Deal Round Up: November 4, 2021
Ubicom Holdings Japan helped gynaecological imaging software developer Illumigyn take its total funding to $33m while Optum took part in a $30m round for health payment technology provider Medallion.
Nov 4, 2021Daily Deal Round Up: November 3, 2021
Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.
Nov 3, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


